Article Details

BerGenBio commences Phase IIa portion of bemcentinib trial for NSCLC

Retrieved on: 2024-03-21 16:52:18

Tags for this article:

Click the tags to see associated articles and topics

BerGenBio commences Phase IIa portion of bemcentinib trial for NSCLC. View article details on hiswai:

Excerpt

The gold standard of business intelligence. ... This development comes after a positive recommendation from the trial's independent drug safety ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up